Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness

In this episode of the podcast "In Good Company," Nicolai Tangen interviews Vas Narasimhan, the CEO of Novartis, exploring his unique background as a physician leading a major pharmaceutical company. They discuss Novartis' strategic focus on innovative medicines, the company's R&D structure, and the role of AI and digital transformation in drug discovery. Narasimhan shares insights on the challenges facing the European pharma industry, Novartis' commitment to global health, and his leadership style, emphasizing the importance of energy, adaptability, and creating possibilities for his teams. He also provides advice for young people, highlighting the value of diverse experiences and continuous learning.